HCM
ANIP icon

Highbridge Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Highbridge Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,800
Closed -$291K – 1420
2016
Q4 		$291K Sell
4,800
-6,200
-56% -$379K 0.01% 989
2016
Q3 		$730K Buy
11,000
+3,400
+45% +$213K 0.01% 653
2016
Q2 		$424K Sell
7,600
-1,600
-17% -$77.8K 0.01% 910
2016
Q1 		$310K Buy
+9,200
New +$312K 0.01% 1168
2015
Q3 		– Sell
-11,500
Closed -$714K – 1507
2015
Q2 		$714K Sell
11,500
-900
-7% -$53.6K 0.01% 838
2015
Q1 		$775K Buy
+12,400
New +$754K 0.01% 829

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return